Substrate Imaging to Guide Primary Prevention Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy Fanciful or Realistic Aim? COMMENT

被引：1
|
作者：
Gupta, Ankur [1 ]
机构：
[1] Henry Ford Hosp, Dept Internal Med, Div Cardiol, Detroit, MI 48202 USA
来源：
JACC-CARDIOVASCULAR IMAGING | 2020年 / 13卷 / 08期
关键词：
cardiac magnetic resonance; implantable cardioverter-defibrillator; positron-emission tomography; ventricular arrhythmia; SUDDEN CARDIAC DEATH; VENTRICULAR-ARRHYTHMIAS; RISK; PREDICTS; SHOCKS; HEART; SCAR; CMR;
D O I：
10.1016/j.jcmg.2020.05.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1767 / 1770
页数：4
相关论文
共 50 条
  • [41] Survival After Primary Prevention Implantable Cardioverter-Defibrillator Placement Among Patients With Chronic Kidney Disease
    Hess, Paul L.
    Hellkamp, Anne S.
    Peterson, Eric D.
    Sanders, Gillian D.
    Al-Khalidi, Hussein R.
    Curtis, Lesley H.
    Hammill, Bradley G.
    Pun, Patrick H.
    Curtis, Jeptha P.
    Anstrom, Kevin J.
    Hammill, Stephen C.
    Al-Khatib, Sana M.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2014, 7 (05) : 793 - 799
  • [42] Serum amine-based metabolites and their association with outcomes in primary prevention implantable cardioverter-defibrillator patients
    Zhang, Yiyi
    Blasco-Colmenares, Elena
    Harms, Amy C.
    London, Barry
    Halder, Indrani
    Singh, Madhurmeet
    Dudley, Samuel C.
    Gutmann, Rebecca
    Guallar, Eliseo
    Hankemeier, Thomas
    Tomaselli, Gordon F.
    Cheng, Alan
    EUROPACE, 2016, 18 (09): : 1383 - 1390
  • [43] Time Dependence of Risks and Benefits in Pediatric Primary Prevention Implantable Cardioverter-Defibrillator Therapy
    DeWitt, Elizabeth S.
    Triedman, John K.
    Cecchin, Frank
    Mah, Doug Y.
    Abrams, Dominic J.
    Walsh, Edward P.
    Gauvreau, Kimberlee
    Alexander, Mark E.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2014, 7 (06) : 1057 - U137
  • [44] Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention?
    Abdelhamid, Magdy
    Rosano, Giuseppe
    Metra, Marco
    Adamopoulos, Stamatis
    Boehm, Michael
    Chioncel, Ovidiu
    Filippatos, Gerasimos
    Jankowska, Ewa A.
    Lopatin, Yury
    Lund, Lars
    Milicic, Davor
    Moura, Brenda
    Ben Gal, Tuvia
    Ristic, Arsen
    Rakisheva, Amina
    Savarese, Gianluigi
    Mullens, Wilfried
    Piepoli, Massimo
    Bayes-Genis, Antoni
    Thum, Thomas
    Anker, Stefan D.
    Seferovic, Petar
    Coats, Andrew J. S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1460 - 1466
  • [45] Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death
    Amara, Nelly
    Boveda, Serge
    Defaye, Pascal
    Klug, Didier
    Treguer, Frederic
    Amet, Denis
    Perier, Marie-Cecile
    Gras, Daniel
    Algalarrondo, Vincent
    Bouzeman, Abdeslam
    Piot, Olivier
    Deharo, Jean-Claude
    Fauchier, Laurent
    Babuty, Dominique
    Bordachar, Pierre
    Sadoul, Nicolas
    Marijon, Eloi
    Leclercq, Christophe
    EUROPACE, 2018, 20 (01): : 65 - 72
  • [46] The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) according to guideline indications in the improve SCA study
    Ching, Chi Keong
    Hsieh, Yu-Cheng
    Liu, Yen-Bing
    Rodriguez, Diego A.
    Kim, Young-Hoon
    Joung, Boyoung
    Singh, Balbir
    Huang, Dejia
    Hussin, Azlan
    Chasnoits, Alexandr R.
    O'Brien, Janet E.
    Cerkvenik, Jeffrey
    Lexcen, Daniel
    Van Dorn, Brian
    Zhang, Shu
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (08) : 2285 - 2294
  • [47] The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape
    Wong, Jorge A.
    Roberts, Jason D.
    Healey, Jeff S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (04) : 644 - 654
  • [48] Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population
    Levy, Wayne C.
    Lee, Kerry L.
    Hellkamp, Anne S.
    Poole, Jeanne E.
    Mozaffarian, Dariush
    Linker, David T.
    Maggioni, Aldo P.
    Anand, Inder
    Poole-Wilson, Philip A.
    Fishbein, Daniel P.
    Johnson, George
    Anderson, Jill
    Mark, Daniel B.
    Bardy, Gust H.
    CIRCULATION, 2009, 120 (10) : 835 - 842
  • [49] Questioning the preference for dual- vs. single-chamber implantable defibrillator in primary prevention implantable cardioverter-defibrillator recipients
    Kutyifa, Valentina
    Theuns, Dominic A. M. J.
    EUROPACE, 2017, 19 (09): : 1416 - 1417
  • [50] Automated electrocardiographic quantification of myocardial scar in patients undergoing primary prevention implantable cardioverter-defibrillator implantation: Association with mortality and subsequent appropriate and inappropriate therapies
    Reichlin, Tobias
    Asatryan, Babken
    Vos, Marc A.
    Willems, Rik
    Huikuri, Heikki, V
    Junttila, M. Juhani
    Schloegl, Simon C.
    Hnatkova, Katerina
    Schaer, Beat A.
    Malik, Marek
    Zabel, Markus
    Sticherling, Christian
    HEART RHYTHM, 2020, 17 (10) : 1664 - 1671
12345